Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
Tetracaine hydrochloride 20 mg/g cutaneous gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
Tetracaine hydrochloride 5 mg/mL cutaneous solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
tetracainhydrochlorid 1 % injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
tetracainhydrochlorid 10 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
tetracainhydrochlorid 5 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
tetracainhydrochlorid 3 mg/ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
Amethocaine adverse reaction |
Causative agent |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
tetracainhydrochlorid 2 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
tetracainhydrochlorid 1 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
tetracainhydrochlorid 0,5 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
benzocain + butamben + tetracainhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
benzocain 14 % wt/wt + butamben 2 % wt/wt + tetracainhydrochlorid 2 % wt/wt salve |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
tetracainhydrochlorid 0,3 %/glucose 6 % injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
tetracainhydrochlorid 0,2 %/glucose 6% injektionsvæske, opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
Amethocaine hydrochloride 1% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
Amethocaine hydrochloride 0.5% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
|
Tetracaine hydrochloride 10 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Tetracaine hydrochloride 10 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Tetracaine hydrochloride 5 mg/mL cutaneous solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Tetracaine hydrochloride 5 mg/mL cutaneous solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Tetracaine hydrochloride 20 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Tetracaine hydrochloride 20 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Tetracaine hydrochloride 5 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Tetracaine hydrochloride 5 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Tetracaine hydrochloride 10 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Tetracaine hydrochloride 10 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release solution for eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 5 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely tetracaine hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Tetracaine hydrochloride |
Inferred relationship |
Some |
1 |